AUXILIUM PHARMACEUTICALS INC's ticker is and the CUSIP is 05334DAA5. A total of 38 filers reported holding AUXILIUM PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2013 | $9,243,000 | – | 9,560,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BTG Pactual Global Asset Management Ltd | 7,000 | $18,370,000 | 2.18% |
| GLAZER CAPITAL, LLC | 6,500,000 | $8,614,000 | 1.88% |
| SILVERBACK ASSET MANAGEMENT LLC | 10,000,000 | $13,210,000 | 1.55% |
| CSS LLC/IL | 23,315,000 | $30,884,000 | 1.50% |
| Man Investments (CH) AG | 1,900,000 | $2,503,000 | 1.31% |
| ANGELO GORDON & CO., L.P. | 9,690,000 | $12,779,000 | 0.84% |
| Pinnacle Holdings, LLC | 1,915,000 | $2,541,741,000 | 0.66% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 22,700,000 | $30,065,000,000 | 0.52% |
| BASSO CAPITAL MANAGEMENT, L.P. | 2,500,000 | $3,297,000 | 0.50% |
| BNP PARIBAS FINANCIAL MARKETS | 3,943,000 | $520,002,848,000 | 0.45% |